Skip to main content

Advertisement

Log in

Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene

  • GENE THERAPY PROTOCOL
  • Published:
Journal of Molecular Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Author information

Authors and Affiliations

Authors

Additional information

Received: 11 July 1996 / Accepted: 13 September 1996

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stingl, G., Bröcker, EB., Mertelsmann, R. et al. Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene. J Mol Med 75, 297–299 (1997). https://doi.org/10.1007/s001090050115

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s001090050115

Keywords

Navigation